Class II · ModerateRecall completed
Metoprolol Succinate Extended Release Tablets
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot # 1220211M, Exp 02/2019
Where it was soldU.S.A. Nationwide including Puerto Rico.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byActavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054
| Distributed by / for | Actavis Pharma, Inc., Parsippany, NJ 07054 |
| NDC | 62037-831-01 |
Show the full FDA record
| Full product label | Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01 |
| Recalling firm | Teva Pharmaceuticals USA |
| Distribution | U.S.A. Nationwide including Puerto Rico. |
| Quantity | 53,451 bottles |
| Recall initiated | 2018-10-19 |
| Report date | 2018-10-31 |
| Recall completed | 2019-04-03 |
| Recall number | D-0129-2019 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | North Wales PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.